Short Interest in SanBio Company Limited (OTCMKTS:SNBIF) Expands By 19.5%

SanBio Company Limited (OTCMKTS:SNBIFGet Rating) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 1,140,900 shares, a growth of 19.5% from the October 15th total of 954,800 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

SanBio Stock Down 3.3 %

SNBIF stock opened at 5.56 on Tuesday. The company has a 50-day simple moving average of 8.94 and a 200 day simple moving average of 9.24. SanBio has a fifty-two week low of 5.56 and a fifty-two week high of 5.75.

SanBio Company Profile

(Get Rating)

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.

Further Reading

Receive News & Ratings for SanBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SanBio and related companies with MarketBeat.com's FREE daily email newsletter.